Home NDC 0169-7955 NDC 0169-7955 - REBINYN This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 0169-7955
Package NDCs from labels 0169-7955-11, 0169-7955-90
Manufacturer Novo Nordisk
Effective date 2022-08-11
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Labels# Label, Manufacturer, Effective date table Label Manufacturer Effective date Type REBINYN - Novo Nordisk Novo Nordisk 2022-08-11 HUMAN PRESCRIPTION DRUG LABEL
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0169-7955-11 REBINYN 4 mL in 1 VIAL, GLASS INJECTION, POWDER, LYOPHILIZED, 4 mL 125 [iU] in 1mL 9 0169-7955-90 REBINYN 4 mL in 1 VIAL, GLASS INJECTION, POWDER, LYOPHILIZED, 4 mL 125 [iU] in 1mL 9
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0169-7955 REBINYN (COAGULATION FACTOR IX RECOMBINANT, GLYCOPEGYLATED) KIT [NOVO NORDISK] 9 Unmatched 20240808_0ea37235-35fd-410d-b8c4-40ba15fe1294.zip